Tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice

Arising from: Abdullah-Sayani A et al. (2006) Nat Clin Pract Oncol 3: 501–516

I was surprised to read the conflict of interest statement for the review by review Abdullah et al. where they declare no conflicts of interest.¹ If one reads the fine print, authors have made a frontal attack on Oncotype Dx^® (though it is correct and completely justified). However, I feel they should declare that they are involved in 70-gene signature and MammaPrint^® (other competing commercial chip), just for the sake of ethical issues.